# Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.

> **NCT00750360** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 883 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** FluarixTM

## Key facts

- **NCT ID:** NCT00750360
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10-03
- **Primary completion:** 2007-12-01
- **Final completion:** 2007-12-28
- **Target enrollment:** 883 (ACTUAL)
- **Last updated:** 2018-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750360, "Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00750360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*